November 16, 2010

FDA Advisory Panel Begins Historic Review of BENLYSTA™

Today, the U.S Food and Drug Administration (FDA) Arthritis Advisory Committee is holding a public hearing on BENLSYTA, an investigational therapy to treat lupus.

We encourage you to click here to view the video statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of America, to learn more about the significance of this potentially historic day.

We invite you to follow us on our Facebook page and Twitter for live updates from the hearing. Come back to tomorrow for a reaction to the day’s events and more updates!

Thank you for your support of the Lupus Foundation of America.

No comments: